Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
6001 North Mayfair Street
Spokane, Washington 99208

Use our guide to learn which trials are right for you!

We've found
3 trials
at this facility
Breast Cancer Clinical Trial
Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
mi
from
Spokane, WA
Click here to add this to my saved trials
Head and Neck Neoplasms Clinical Trial
Study of Pembrolizumab (MK-3475) or Placebo With Chemoradiation in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-412/KEYNOTE-412)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
mi
from
Spokane, WA
Click here to add this to my saved trials
Renal Cell Carcinoma Clinical Trial
Safety and Efficacy Study of Pembrolizumab (MK-3475) as Monotherapy in the Adjuvant Treatment of Renal Cell Carcinoma Post Nephrectomy (MK-3475-564/KEYNOTE-564)
Status: Enrolling, Phase III
Updated: 12/31/1969
Medical Oncology Associates (Summit Cancer Centers) ( Site 0014)
mi
from
Spokane, WA
Click here to add this to my saved trials